sEV-CC16, encapsulated in extracellular vesicles, has the potential to reduce the inflammatory and DNA damage responses in LPS or bacteria-induced ALI mouse models by attenuating the NF-κB pathway [53]. Here, NFKB1 is linked to acute respiratory distress syndrome.